Clinical trial
A multicenter, prospective, phase 2 trial on proton re‐irradiation for patients with previously treated head and neck cancer
E. Dee
C. A. Barker
N. Kalman
Ying-Zhi Wu
Charlie White
Zhi-Gang Zhang
Hai-Bo Lin
D. Gelblum
Yao Yu
J. Kang
C. Tsai
K. Zakeri
Linda Chen
S. McBride
A. Shamseddine
L. Michel
Lara A. Dunn
Alan L. Ho
Marc A. Cohen
I. Ganly
J. Cracchiolo
Richard J. Wong
P. Romesser
N. Riaz
Eric J. Sherman
Nancy Y. Lee
Medicine
Abstract
Re‐irradiation (re‐RT) for recurrent head and neck cancer (HNC) can be potentially curative but is constrained by significant toxicity. Proton therapy may improve the therapeutic ratio. This multicenter phase 2 trial evaluated the safety and efficacy of proton re‐RT in patients with HNC.